Enveric Biosciences Secures USPTO Patent For Neuroplastogenic Compounds, Expanding IP Assets For Potential Treatment Of Mental Health Disorders

Enveric Biosciences Inc Ordinary Shares +11.13%

Enveric Biosciences Inc Ordinary Shares

ENVB

6.79

+11.13%

Enveric Biosciences Secures USPTO Patent For Neuroplastogenic Compounds, Expanding IP Assets For Potential Treatment Of Mental Health Disorders
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via